Yes, Pernicious Anemia Can Present with Normal Serum B12 Levels
Yes, it is absolutely possible to have pernicious anemia despite a normal serum vitamin B12 level, and this occurs due to anti-intrinsic factor antibody interference with competitive-binding laboratory assays. This is a critical diagnostic pitfall that can delay treatment and lead to irreversible neurological damage.
The Mechanism Behind False-Normal Results
Anti-intrinsic factor antibodies, which are diagnostic of pernicious anemia, can directly interfere with competitive-binding chemiluminescence assays (CBLA) used to measure serum B12 1, 2, 3. These antibodies bind to the intrinsic factor used in the assay reagent, creating falsely normal or even elevated B12 readings despite severe tissue deficiency. This interference has been documented in multiple recent cases where patients had:
- High titers of anti-intrinsic factor antibodies
- Fluctuating but persistently "normal" B12 levels on standard assays
- Collapsed B12 levels when measured by alternative methods (electrochemiluminescence) or after immunoglobulin removal 2
When to Suspect Pernicious Anemia Despite Normal B12
You must pursue pernicious anemia diagnosis when clinical and laboratory features suggest B12 deficiency, regardless of the serum B12 level. Look for these specific indicators 4, 1, 5:
Hematologic Red Flags:
- Macrocytic anemia (MCV elevated)
- Pancytopenia or isolated cytopenias
- Elevated LDH with indirect hyperbilirubinemia (pseudo-hemolysis from ineffective erythropoiesis)
- Low/inappropriately normal reticulocyte count
- Trilineage dysplasia on bone marrow (can mimic myelodysplastic syndrome)
Neurological Red Flags:
- Symmetric paresthesias in hands or feet
- Gait instability, ataxia, or balance problems
- Subacute combined degeneration findings on spinal MRI (T2 hyperintensities in posterior columns)
- Cognitive difficulties ("brain fog"), memory loss
- Visual disturbances from optic neuropathy
Critical Point:
Neurological symptoms can precede hematologic abnormalities entirely 6. Never exclude pernicious anemia based solely on normal hemoglobin or normal B12 levels when neuropsychiatric symptoms are present.
Diagnostic Algorithm When B12 Appears Normal
When clinical suspicion is high but serum B12 is normal, proceed systematically 5, 1:
Measure functional markers immediately:
- Serum homocysteine (elevated in B12 deficiency)
- Methylmalonic acid (MMA) - elevated in B12 deficiency
- These bypass assay interference and reflect actual tissue B12 status
Test for anti-intrinsic factor antibodies:
Consider alternative B12 assay methods:
Evaluate for atrophic gastritis:
- Anti-parietal cell antibodies
- Gastroscopy with biopsy if indicated
Treatment Implications
Do not delay treatment while awaiting confirmatory testing if clinical suspicion is high 1, 3. The cases demonstrate that:
- Intramuscular B12 (mecobalamin or cyanocobalamin) produces rapid improvement in both hematologic and neurological manifestations
- Neurological damage can become irreversible if treatment is delayed
- Response to treatment itself serves as diagnostic confirmation
Common Pitfalls to Avoid
Never dismiss pernicious anemia based solely on "normal" B12 levels when macrocytosis, cytopenias, or neurological symptoms are present 5
Don't misdiagnose as myelodysplastic syndrome - bone marrow dysplasia from B12 deficiency is completely reversible with treatment 3
Don't confuse with hemolytic anemia or TTP - the elevated LDH and low haptoglobin reflect ineffective erythropoiesis, not true hemolysis (reticulocyte count will be inappropriately low) 7, 8
Don't assume demographic protection - while classically described in older Northern Europeans, pernicious anemia occurs across all ages and ethnicities 7
The NICE guideline acknowledges that active B12 (holotranscobalamin) may be more accurate than total B12, though evidence is limited 4. However, even active B12 can be affected by antibody interference, making functional markers (homocysteine, MMA) essential when clinical suspicion persists despite normal results.